Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.25p
   
  • Change Today:
      0.010p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 10,785,074
  • Market Cap: £5.26m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
58.07% below the market average58.07% below the market average58.07% below the market average58.07% below the market average58.07% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
47.40% above the market average47.40% above the market average47.40% above the market average47.40% above the market average47.40% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Price Book Ratio
50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Price Chg 3m
49.45% below the market average49.45% below the market average49.45% below the market average49.45% below the market average49.45% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Momentum 20
28.24% below the market average28.24% below the market average28.24% below the market average28.24% below the market average28.24% below the market average
20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
56.16% below the market average56.16% below the market average56.16% below the market average56.16% below the market average56.16% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.05% below the market average87.05% below the market average87.05% below the market average87.05% below the market average87.05% below the market average
76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average
Operating Profit Loss
69.77% below the market average69.77% below the market average69.77% below the market average69.77% below the market average69.77% below the market average
6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
64.95% below the market average64.95% below the market average64.95% below the market average64.95% below the market average64.95% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average
Cash
42.66% below the market average42.66% below the market average42.66% below the market average42.66% below the market average42.66% below the market average
34.78% below the sector average34.78% below the sector average34.78% below the sector average34.78% below the sector average34.78% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.25p
Change Today 0.010p
% Change 4.26 %
52 Week High 1.22
52 Week Low 0.20
Volume 10,785,074
Shares Issued 2,148.96m
Market Cap £5.26m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.95% below the market average43.95% below the market average43.95% below the market average43.95% below the market average43.95% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Price Trend
94.73% below the market average94.73% below the market average94.73% below the market average94.73% below the market average94.73% below the market average
82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average
Income Not Available
Growth
16.63% below the market average16.63% below the market average16.63% below the market average16.63% below the market average16.63% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Theracryf Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
13:30 1,000,000 @ 0.26p
12:21 2,000,000 @ 0.26p
12:20 467 @ 0.27p
12:20 1,000 @ 0.22p
12:20 250 @ 0.27p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page